ImportRefusal LogoImportRefusal

Abbott Laboratories

⚠️ High Risk

FEI: 1415939 • Abbott Park, IL • UNITED STATES

FEI

FEI Number

1415939

📍

Location

Abbott Park, IL

🇺🇸
🏢

Address

100 Abbott Park Rd Bldg Ap8b, , Abbott Park, IL, United States

High Risk

FDA Import Risk Assessment

67.7
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

43
Total Refusals
8
Unique Violations
12/19/2025
Latest Refusal
6/26/2002
Earliest Refusal

Score Breakdown

Violation Severity
69.6×40%
Refusal Volume
60.9×30%
Recency
98.8×20%
Frequency
18.3×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

17919×

AGR RX

The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.

7517×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1186×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

271×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

3411×

REGISTERED

It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).

37411×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(o) in that it is being imported or offered for import into the United States, and the importer, owner, or consignee of such article did not, at the time of offering the article for import, submit to the Secretary a statement that identifies the registration under section 510(i) of the Act of each establishment that with respect to such article is required under such section to register with the Secretary.

5081×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

1861×

INSANITARY

The article is subject to refusal of admission pursuant to section 801(a)(3) in that the article appears to have been prepared, packed, or held under insanitary conditions whereby it may have been contaminated with filth, or whereby it may have been rendered injurious to health.

Refusal History

DateProductViolationsDivision
12/19/2025
64MDY01CLOMIPHENE CITRATE (GONAD-STIMULATING PRINCIPLE)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/12/2025
66TCE03FEBUXOSTAT (XANTHINE OXIDASE INHIBITOR)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/4/2025
58SCY14ADALIMUMAB
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/4/2025
58SDY14ADALIMUMAB
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/7/2025
58SCK14ADALIMUMAB
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/7/2025
58SCY14ADALIMUMAB
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/6/2025
58SCY14ADALIMUMAB
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/8/2022
66JCY01LEVOTHYROXINE SODIUM (THYROID HORMONE)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/11/2022
83QLWCOVID-19 TEST HOME COLLECTION KIT DEVICES
508NO 510(K)
Division of West Coast Imports (DWCI)
12/27/2021
61FCC56CLARITHROMYCIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/28/2021
62OCY10TERAZOSIN HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/5/2019
66SCA03BETAHISTINE HCL (VASODILATOR)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/22/2019
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/4/2019
66JCB01LEVOTHYROXINE SODIUM (THYROID HORMONE)
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/28/2018
62IDY86LEUPROLIDE ACETATE (ANTI-NEOPLASTIC)
118NOT LISTED
75UNAPPROVED
Division of Northern Border Imports (DNBI)
4/4/2013
62VIY37RITONAVIR (ANTI-VIRAL)
27DRUG GMPS
3741FRNMFGREG
Florida District Office (FLA-DO)
4/6/2012
56IDA10ERYTHROMYCIN (MACROLIDES)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/26/2008
56YIP99ANTIBIOTIC N.E.C.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
10/2/2007
61LDP26ARDEPARIN SODIUM (ANTI-COAGULANT)
75UNAPPROVED
New Orleans District Office (NOL-DO)
6/28/2005
62VCA13RIMANTADINE HCL (ANTI-VIRAL)
179AGR RX
New Orleans District Office (NOL-DO)
11/2/2004
60QDS67LIDOCAINE (ANESTHETIC)
186INSANITARY
Southwest Import District Office (SWI-DO)
3/12/2004
61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION
179AGR RX
Chicago District Office (CHI-DO)
3/12/2004
60CCP04EPINEPHRINE (ADRENERGIC)
179AGR RX
Chicago District Office (CHI-DO)
3/12/2004
61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION
179AGR RX
Chicago District Office (CHI-DO)
3/12/2004
60CCP04EPINEPHRINE (ADRENERGIC)
179AGR RX
Chicago District Office (CHI-DO)
8/27/2003
61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION
179AGR RX
Chicago District Office (CHI-DO)
8/27/2003
60CCP04EPINEPHRINE (ADRENERGIC)
179AGR RX
Chicago District Office (CHI-DO)
8/27/2003
61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION
179AGR RX
Chicago District Office (CHI-DO)
8/27/2003
60CCP04EPINEPHRINE (ADRENERGIC)
179AGR RX
Chicago District Office (CHI-DO)
6/26/2003
61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION
179AGR RX
Chicago District Office (CHI-DO)
6/26/2003
60CCP04EPINEPHRINE (ADRENERGIC)
179AGR RX
Chicago District Office (CHI-DO)
5/1/2003
61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION
179AGR RX
Chicago District Office (CHI-DO)
5/1/2003
60CCP04EPINEPHRINE (ADRENERGIC)
179AGR RX
Chicago District Office (CHI-DO)
5/1/2003
61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION
179AGR RX
Chicago District Office (CHI-DO)
5/1/2003
60CCP04EPINEPHRINE (ADRENERGIC)
179AGR RX
Chicago District Office (CHI-DO)
3/31/2003
61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION
179AGR RX
Chicago District Office (CHI-DO)
3/31/2003
60CCP04EPINEPHRINE (ADRENERGIC)
179AGR RX
Chicago District Office (CHI-DO)
3/31/2003
61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION
118NOT LISTED
Chicago District Office (CHI-DO)
3/31/2003
60CCP04EPINEPHRINE (ADRENERGIC)
118NOT LISTED
Chicago District Office (CHI-DO)
12/3/2002
61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION
179AGR RX
Chicago District Office (CHI-DO)
12/3/2002
60CCP04EPINEPHRINE (ADRENERGIC)
179AGR RX
Chicago District Office (CHI-DO)
7/23/2002
56IXS10ERYTHROMYCIN (MACROLIDES)
118NOT LISTED
New York District Office (NYK-DO)
6/26/2002
88JCCPH BUFFER
118NOT LISTED
341REGISTERED
Chicago District Office (CHI-DO)

Frequently Asked Questions

What is Abbott Laboratories's FDA import refusal history?

Abbott Laboratories (FEI: 1415939) has 43 FDA import refusal record(s) in our database, spanning from 6/26/2002 to 12/19/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Abbott Laboratories's FEI number is 1415939.

What types of violations has Abbott Laboratories received?

Abbott Laboratories has been cited for 8 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Abbott Laboratories come from?

All FDA import refusal data for Abbott Laboratories is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.